Cargando…
How we treat Merkel cell carcinoma: within and beyond current guidelines
Merkel cell carcinoma (MCC) is an aggressive skin cancer associated with a high risk of local recurrence and distant metastasis. Optimal care of this potentially life-threatening cancer is critical but challenging because: physicians are often unfamiliar with its management due to rarity, and MCC ma...
Autores principales: | Park, Song Y, Doolittle-Amieva, Coley, Moshiri, Yasman, Akaike, Tomoko, Parvathaneni, Upendra, Bhatia, Shailender, Zaba, Lisa C, Nghiem, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983043/ https://www.ncbi.nlm.nih.gov/pubmed/33511866 http://dx.doi.org/10.2217/fon-2020-1036 |
Ejemplares similares
-
Complete resolution of PD-1 refractory, locoregionally advanced Merkel cell carcinoma with talimogene laherparepvec
por: Singh, Neha, et al.
Publicado: (2023) -
How I treat AML incorporating the updated classifications and guidelines
por: El Chaer, Firas, et al.
Publicado: (2023) -
Allogeneic Hematopoietic Cell Transplantation in the Treatment of Chronic Lymphocytic Leukemia: Why and When?
por: Delioukina, Maria L., et al.
Publicado: (2010) -
Hematopoietic Stem Cell Transplantation in Thalassemia and Sickle Cell Disease. Unicenter Experience in a Multi-Ethnic Population.
por: Marziali, Marco, et al.
Publicado: (2009) -
Newly Diagnosed Acute Promyelocytic Leukemia
por: Avvisati, Giuseppe
Publicado: (2011)